IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Canaan Partners IX LLC

Q3 2016 Holdings

Filed 2016-10-07 | 1 holdings | $66.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
CytomX Therapeutics, Inc.(CTMX)COM23284F105$66.6M4,244,381100.0%